Related Experiment Video
Updated: Jun 29, 2026
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
[Pneumonia with empyema during varicella]
Summary
Bacterial pneumonia with empyema is a rare but serious complication of chicken pox. Early recognition during prolonged fever or health decline is crucial for prompt treatment in children.
Area of Science:
- Pediatric Infectious Diseases
- Pulmonology
- Critical Care Medicine
Context:
- Chicken pox (varicella) is typically a mild viral illness.
- While skin infections are common, severe complications like bacterial pneumonia with empyema are infrequently reported.
- Understanding these rare but severe complications is vital for pediatric healthcare providers.
Purpose:
- To delineate the clinical features of bacterial pneumonia and empyema occurring concurrently with chicken pox.
- To identify key indicators for diagnosing this severe complication in pediatric patients.
Summary:
- A retrospective study identified 4 pediatric cases (mean age 19 months) of bacterial pneumonia with empyema during chicken pox.
- Diagnosis occurred around 4.5 days post-eruption, with all children presenting fever, hypoxia (avg. 87% SpO2), and significant inflammation (avg. CRP 253 mg/l).
- Group A Streptococcus was implicated in 3 cases; 3 children required intensive care, with one needing mechanical ventilation. No sequelae were noted after one year.
Impact:
- Highlights that bacterial pneumonia with empyema, though uncommon, necessitates vigilance during chicken pox.
- Emphasizes the importance of seeking these complications in cases of persistent fever or deteriorating health status.
- Informs clinical practice regarding the prompt diagnosis and management of severe varicella-associated respiratory infections.
Related Concept Videos
01:20Chickenpox
Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: